This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Unsuccessful developing lung cancer drugs in the U.S. 1998-2014
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014
This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Loading statistic...
| Number of drugs no longer under development | |
|---|---|
| 2014 | 6 |
| 2013 | 23 |
| 2012 | 11 |
| 2011 | 13 |
| 2010 | 14 |
| 2009 | 11 |
| 2008 | 15 |
| 2007 | 25 |
| 2006 | 6 |
| 2005 | 7 |
| 2004 | 11 |
| 2003 | 4 |
| 2002 | 8 |
| 2001 | 4 |
| 2000 | 3 |
| 1999 | 4 |
| 1998 | 2 |
| Number of drugs no longer under development | |
|---|---|
| 2014 | 6 |
| 2013 | 23 |
| 2012 | 11 |
| 2011 | 13 |
| 2010 | 14 |
| 2009 | 11 |
| 2008 | 15 |
| 2007 | 25 |
| 2006 | 6 |
| 2005 | 7 |
| 2004 | 11 |
| 2003 | 4 |
| 2002 | 8 |
| 2001 | 4 |
| 2000 | 3 |
| 1999 | 4 |
| 1998 | 2 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Show more- Show sources information
- Show publisher information
- Release date
- October 2014
- Region
- United States
- Survey time period
- 1998 to 2014
More information
- Region
- United States
- Survey time period
- 1998 to 2014
Other interesting statistics
Number of active physicians in the U.S. 2018 by specialty area
+
+Deaths by cancer in the U.S. 1950-2016
+
+Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
Global top pharmaceutical companies by oncology market share 2017 and 2024
+
+Bristol-Myers Squibb's top products based on revenue 2008-2017
+
+Global death rate - leading causes 2016
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Oncology"
- Cancer facts
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Number of cancer deaths worldwide in 2016, by major type of cancerCancer deaths worldwide by major type 2016
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)U.S. Americans with a history of cancer living 2004-2016
- Number of new cancer cases in the United States from 1999 to 2015*Number of new cancer cases in U.S. from 1999 to 2015
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Oncology market
The most important statistics
- Global oncology spending from 2010 to 2017 (in billion U.S. dollars)*Global oncology costs 2010-2017
- Projected growth and spending in oncology market globally from 2012 to 2022 (in billion U.S. dollars)Expenditure and growth worldwide in oncology market 2012-2022
- Global oncology therapeutic medicine spending in the period 2013-2017, by regionOncology medicine spending growth 2013-2017, by region
- Projected global oncology spending in 2022, by region (in billion U.S. dollars)Predicted oncology spending in 2022, by region
- Emerging cancer diagnostics market size worldwide in 2015 and 2023, by region (in billion U.S. dollars)Emerging cancer diagnostics market size by world region 2015 and 2023
- Growth of the U.S. oncology therapeutic market from 2012 to 2017, by segment (in billion U.S. dollars)Oncology therapeutic market growth U.S. 2012-2017, by segment
- Companies
The most important statistics
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
- Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024Global top pharmaceutical companies by oncology market share 2017 and 2024
- Revenue distribution of Roche's Pharmaceuticals division in 2017 and 2018, by therapeutic areaRevenue share of Roche's Pharmaceuticals division by therapy area 2017-2018
- Revenues of biotech company Celgene's top products from 2012 to 2017 (in million U.S. dollars)Celgene's top product revenues 2012-2017
- Bristol-Myers Squibb's top products based on revenue from 2008 to 2017 (in million U.S. dollars)Bristol-Myers Squibb's top products based on revenue 2008-2017
- Venture investments in oncology companies in the U.S. from 2006 to 2017 (in million U.S. dollars)U.S. venture investments in oncology companies 2006-2017
- Amount raised through initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2017 (in million U.S. dollars)*U.S. oncology company IPO money raised 2006-2017
- Cancer drugs
The most important statistics
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*Top 5 worldwide oncology products by revenue 2017 and 2024
- Top 5 oncology products worldwide by market share in 2017 and 2024Top 5 worldwide oncology products by market share 2017 and 2024
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017Availability of new cancer drugs by country as of 2017
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)Top U.S. oncology products by revenue in 2016
- Number of oncology drugs by treatment cost and number of patients in the U.S. as of 2017Number of cancer drugs by cost and number of patients U.S. 2017
- Research and development
The most important statistics
- Distribution of FDA breakthrough therapy requests by therapy area in 2018FDA on breakthrough therapy requests by therapy area 2018
- Distribution of FDA breakthrough therapy requests granted by therapy area in 2018FDA on breakthrough therapy requests granted by therapy area 2018
- Distribution of late phase oncology pipeline in 2007 and 2017, by typeDistribution of late phase oncology pipeline in 2017 by type
- Number of cancer drugs in development in the United States in select years between 2005 and 2018Number of cancer drugs in development in the U.S. 2005-2018
- Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years) Time from R&D start to approval of select cancer drugs 2017
- Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)Total R&D costs including costs of capital for select cancer drugs 2017
- Immuno-oncology
The most important statistics
- Top 10 mechanisms of action in R&D pipeline drugs worldwide by number of active compounds in 2018*Worldwide top drug producing mechanisms of action by number of active compounds 2018
- Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of actionDistribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
- Global cancer immunotherapy market in 2016 and projection for 2022 (in billion U.S. dollars)Global cancer immunotherapy market size 2016 and 2022 forecast
- Market share forecast for top immuno-oncology companies worldwide in 2021*Global cancer immunotherapy sales share by type 2021 forecast
- Top 10 immuno-oncology collaborations worldwide based on value as of 2018 (in billion U.S. dollars)Leading cancer immunotherapy collaborations worldwide by value 2018
- Treatment types
The most important statistics
- Distribution of treatment types for female breast cancer in the U.S. in 2013, by stageDistribution of treatment types for female breast cancer by stage 2013
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012Distribution of treatment types for prostate cancer 2010-2012
- Distribution of treatment types for colon cancer in the U.S. in 2013, by stageDistribution of treatment types for colon cancer by stage 2013
- Distribution of treatment types for lung cancer in the U.S. in 2013*Distribution of treatment types for lung cancer in the U.S. 2013
- Distribution of treatment types for non-Hodgkin lymphoma in the U.S. in 2013Distribution of treatment types for non-Hodgkin lymphoma 2013
- Physicians and patients
The most important statistics
- Number of oncologists per one million people in select countries as of 2018Number of oncologists per one million people by select country 2018
- Number of active physicians in the U.S. in 2018, by specialty areaNumber of active physicians in the U.S. 2018 by specialty area
- Hours per week that oncologists in the U.S. spend seeing patients as of 2018Number of hours U.S. oncologists spend a week seeing patients 2018
- Minutes that oncologists in the U.S. spend with each patient as of 2018Number of minutes U.S. oncologists spend with each patient 2018
- Medication usage among patients with cancer in selected countries as of 2018*Cancer patients using medication in select countries 2018
- Lifestyle among patients with cancer in selected countries as of 2018*Cancer sufferers based on lifestyle habits by select country 2018
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)Inpatient average length of stay in U.S. hospitals by cancer type 2008-2016
- Percentage of patients whose tumors are driven by certain genetic mutations as of 2016, by cancer typePatients whose tumors are driven by genetic mutations by cancer type 2016
Popular Related Keywords
- success
- lung cancer
- abandonment
- cancer drugs
- Show more
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Unsuccessful developing melanoma drugs in the U.S. 1998-2014
- Unsuccessful developing brain cancer drugs in the U.S. 1998-2014
- Revenue since approval for select cancer drugs 2017
- Average prices of Gleevec - selected countries 2013
- Revenue as a part of R&D spending for select cancer drugs 2017
- Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017
- Italy: consumption of cancer drugs 2017, by region
- Net price index for cancer products in developed markets 2014
- U.S. average invoice price increase for oncology brands 2012-2017
- Metastatic cancer treatment market worldwide 2017 and 2025
- Italy: public expenditure on the most prescribed drugs 2017, by category
- Italy: public expenditure on innovative drugs 2015-2017
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Italy: number of clinical trials for rare diseases 2017, by funding institution
- Italy: number of clinical trials for rare diseases 2017, by type of drug
- Italy: number of clinical trials 2017, by type of drug
- Cancer drugs on the world market 2010
- Prescription drug price development in the U.S. by select drug 2010-2017
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2017
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2017
Statistics on the topic
Free statistics
- Number of cancer deaths worldwide in 2016, by major type of cancer
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)
- Global oncology spending from 2010 to 2017 (in billion U.S. dollars)*
- Growth of the U.S. oncology therapeutic market from 2012 to 2017, by segment (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on global oncology market share in 2017 and 2024
- Revenue distribution of Roche's Pharmaceuticals division in 2017 and 2018, by therapeutic area
- Number of oncology drugs by treatment cost and number of patients in the U.S. as of 2017
- Distribution of late phase oncology pipeline in 2007 and 2017, by type
- Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)
- Top 10 mechanisms of action in R&D pipeline drugs worldwide by number of active compounds in 2018*
- Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action
- Distribution of treatment types for prostate cancer in the U.S. in 2010-2012
- Distribution of treatment types for non-Hodgkin lymphoma in the U.S. in 2013
- Number of oncologists per one million people in select countries as of 2018
- Number of active physicians in the U.S. in 2018, by specialty area
- Medication usage among patients with cancer in selected countries as of 2018*
- Average length of stay in U.S. hospitals per inpatient cancer cases from 2008 to 2016 (in days)
- Average prices of Gleevec in selected countries in 2013 (in U.S. dollars)
- Global metastatic cancer treatment market in 2017 and 2025 (in billion U.S. dollars)
- Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2017
- AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2017
Premium Statistics
- Leading causes of death worldwide in 2016 (in millions)
- Number of new cancer cases in the United States from 1999 to 2015*
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*
- Projected growth and spending in oncology market globally from 2012 to 2022 (in billion U.S. dollars)
- Global oncology therapeutic medicine spending in the period 2013-2017, by region
- Projected global oncology spending in 2022, by region (in billion U.S. dollars)
- Emerging cancer diagnostics market size worldwide in 2015 and 2023, by region (in billion U.S. dollars)
- Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)
- Revenues of biotech company Celgene's top products from 2012 to 2017 (in million U.S. dollars)
- Bristol-Myers Squibb's top products based on revenue from 2008 to 2017 (in million U.S. dollars)
- Venture investments in oncology companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Amount raised through initial public offerings (IPOs) from oncology companies in the U.S. from 2006 to 2017 (in million U.S. dollars)*
- Top 5 oncology products worldwide based on revenue in 2017 and 2024 (in million U.S. dollars)*
- Top 5 oncology products worldwide by market share in 2017 and 2024
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017
- Leading U.S. oncology brands based on revenue in 2016 (in million U.S. dollars)
- Distribution of FDA breakthrough therapy requests by therapy area in 2018
- Distribution of FDA breakthrough therapy requests granted by therapy area in 2018
- Number of cancer drugs in development in the United States in select years between 2005 and 2018
- Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years)
- Global cancer immunotherapy market in 2016 and projection for 2022 (in billion U.S. dollars)
- Market share forecast for top immuno-oncology companies worldwide in 2021*
- Top 10 immuno-oncology collaborations worldwide based on value as of 2018 (in billion U.S. dollars)
- Distribution of treatment types for female breast cancer in the U.S. in 2013, by stage
- Distribution of treatment types for colon cancer in the U.S. in 2013, by stage
- Distribution of treatment types for lung cancer in the U.S. in 2013*
- Hours per week that oncologists in the U.S. spend seeing patients as of 2018
- Minutes that oncologists in the U.S. spend with each patient as of 2018
- Lifestyle among patients with cancer in selected countries as of 2018*
- Percentage of patients whose tumors are driven by certain genetic mutations as of 2016, by cancer type
- Number of unsuccessful melanoma drugs in development in the United States from 1998 to 2014
- Number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014
- Total revenue since approval for select cancer drugs on the market as of 2017 (in million U.S. dollars)
- Revenue as a percentage of R&D spending for select cancer drugs on the market as of 2017
- Number of new cancer pharmaceuticals approved by EMA (European Medicines Agency) in Sweden from 2014 to 2017
- Level of consumption of cancer drugs in Italy in 2017, by region (in DDD* per 1,000 inhabitants per day)
- Net price index for oncology products in selected developed markets as of 2014*
- Invoice price increases for protected oncology brands in the U.S. from 2012 to 2017
- Public expenditure on the most prescribed drugs in Italy in 2017, by category (in million euros)
- Public expenditure on innovative drugs in Italy from 2015 to 2017 (in million euros)
- Estimated size of the anti-cancer drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)
- Number of clinical trials* to treat rare diseases in Italy in 2017, by funding institution
- Number of clinical trials* to treat rare diseases in Italy in 2017, by type of drug
- Number of clinical trials authorized by the Italian Medicines Agency in Italy in 2017, by type of drug
- Proportion of cancer drugs on the world market from 2004 to 2010
- Selected prescription drug prices in the U.S. in 2010 and 2017 (in U.S. dollars)*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
News
News
Latest News
Updated
The Italian pharmaceutical market
The Italian pharmaceutical market is among the fastest growing ones worldwide. This dossier provides data on the trends of the market, with special focus on pharmaceutical segments.
Updated
Update & expansion: Country Reports
To our 150 Reports we added:
- Global Consumer Survey content
- Operational risk index by Fitch
- And more …
New
New Dossier: Plastic industry worldwide
The global plastics industry is growing by approximately three percent every year. This dossier provides information about the global plastics industry in general as well as chapters on the major types of plastic, and recycling rates.
Updated
New Digital Market Outlook Reports for 2019
Updates on eCommerce, Digital Media, eTravel, eServices and more
- Market figures for 2018 to 2023
- Company and startup profiles
- User demographics
New
New Dossier: United States coal mining industry
U.S. coal production has steadily declined in the past decade, but has been in the news in recent years due to President Trump's desire to revitalize the industry. This document provides an overview of the key figures, leading companies, and the employment trends in the U.S. coal mining industry.
New
Global Consumer Survey offers PowerPoint export
This new export feature offers
- Structured graphical representation of the data
- Tailored target group analysis
- Option for further processing
New
New Dossier: E-commerce in Poland
The Polish e-commerce market is one of the fastest developing e-commerce markets in Europe. The latest data for Poland is presented in this dossier.
New
New Dossier: Plastic waste in the U.S.
Plastic waste is an issue of global concern. Since China banned the import of recycled plastic, the U.S. has had to make adjustments to its management of plastic waste. This dossier provides an overview of plastic waste in the U.S.
New
New Dossier: Hedge funds
This dossier provides an overview of hedge funds worldwide. Global hedge fund assets, performance, investors, and other topics are highlighted.
New
New exclusive OOH advertising data by OAAA
The Outdoor Advertising Association of America covers amongst others
- Number of billboards
- Outdoor advertising revenue
- Number of out-of-home displays
New
What happens after a no-deal Brexit?
Find data, perceptions & more about
- Economic consequences
- Impact on the labor market
- A second referendum
New
ecommerceDB.com: Ranking update – Spain
Understand the recent developments in the Spanish eCommerce market!
- URL-related revenues
- Relevant online store KPIs
- eCommerce-related contacts
New
Insights into the European banking sector
- Extended statistical dossier
- Insights, explanations & interpretations
- Challenges of the digital future
New
Dossier: Latin American online shopping events
eCommerce is rapidly becoming a part of the Latin American shopping culture. The dossier includes data on
- Regional online shopping events
- Events by country
Updated
Updated Brexit analysis in UK Industry Reports
The outline of potential impacts of Brexit on UK industries has been updated in the UK Industry Reports.
New
New Dossier: Digital Marketing in Italy
Italian enterprises invest significantly in digital marketing. Find out about
- Relevant aspects & KPIs
- New trends
- Different strategies
New
What is football all about, anyway?
Statista European Football Benchmark
- The big 5 European leagues
- All about the clubs & fans
- Sponsors & how they fit in
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.